CSF logo

CSF ETF

Profile

Name:

VictoryShares US Discovery Enhanced Volatility Wtd ETF

Assets under management:

$41 M

Expense ratio:

0.42%

Inception date:

01 August 2014

Website:

-

Last ex-dividend date:

07 November 2024

Next ex-dividend date:

N/A

Description:

CSF ETF is an exchange-traded fund that focuses on companies involved in cybersecurity. It aims to provide investors with exposure to the growing cybersecurity sector, which protects systems and data from cyber threats. The fund offers a diversified portfolio of stocks in this important industry.
Name
Weight
0.47 %
CASH AND CASH EQUIVALENTS
0.39 %
IDA logo
IDACORP(IDA)
0.38 %
0.37 %
SR logo
Spire(SR)
0.35 %
0.34 %
0.33 %

Holding types

Countries

Sectors

Analyst ratings

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series
Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal Metastases
Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal Metastases
Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal Metastases
CSF
globenewswire.com22 November 2024

The FORESEE trial of the CNSide Cerebrospinal Fluid (CSF) Assay successfully achieved its main and secondary goals. The assay significantly impacted clinical management decisions in more than 90% of cases involving leptomeningeal metastases, showing 2.8 times greater diagnostic sensitivity compared to standard cytology. CNSide Diagnostics, a subsidiary of Plus Therapeutics, will share findings from the trial that highlight the assay's effectiveness in diagnosing and informing treatment for patients with breast cancer and non-small cell lung cancer who have LM.

FAQ

  • What is CSF ETF?
  • Does CSF pay dividends?
  • What stocks are in CSF ETF?
  • What is the current assets under management for CSF?
  • What is CSF average volume?
  • What is CSF expense ratio?
  • What is CSF inception date?

What is CSF ETF?

CSF ETF is an exchange-traded fund that focuses on companies involved in cybersecurity. It aims to provide investors with exposure to the growing cybersecurity sector, which protects systems and data from cyber threats. The fund offers a diversified portfolio of stocks in this important industry.

Does CSF pay dividends?

Yes, the VictoryShares US Discovery Enhanced Volatility Wtd ETF does pays dividends, with the most recent payment being $0.02 per share. The last ex-dividend date was on 07 November 2024, and the next ex-dividend date has not been announced yet

What stocks are in CSF ETF?

As of today, VictoryShares US Discovery Enhanced Volatility Wtd ETF inlcudes 504 holdings, with 499 of them being companies from 2 different countries and 11 sectors. The most weighted holdings are DT Midstream (0.47%), CASH AND CASH EQUIVALENTS (0.39%) and IDACORP (0.38%)

What is the current assets under management for CSF?

Assets under management of VictoryShares US Discovery Enhanced Volatility Wtd ETF is $41 M

What is CSF average volume?

Average volume of VictoryShares US Discovery Enhanced Volatility Wtd ETF is $4117

What is CSF expense ratio?

Expense ratio of VictoryShares US Discovery Enhanced Volatility Wtd ETF is 0.42%

What is CSF inception date?

Inception date of VictoryShares US Discovery Enhanced Volatility Wtd ETF is 01 August 2014